Pricing Log in Create free account

BGM Group Ltd. (BGM) vs Citius Oncology, Inc. (CTOR)

BGM Group Ltd. and Citius Oncology, Inc. are both Drug Manufacturers Specialty & Generic companies. BGM Group Ltd. is the larger, with a market value of $114.7M against $69.4M — 1.7× the size. Citius Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 144×. BGM Group Ltd. has the higher net margin (1.96% vs 0.00%) and the higher return on invested capital (0.00% vs −67.2%). Across the 10 metrics below, BGM Group Ltd. leads on 9 and Citius Oncology, Inc. on 1.

Valuation

Metric BGM CTOR Drug Manufacturers Specialty & Generic median
P/E 144.17 n/m 19.25
P/S n/m n/m 2.11
P/B n/m 2.00 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales (0.09) n/m 2.73
Earnings yield 0.69% (62.67%) (4.38%)
Free cash flow yield 0.00% (39.72%) 0.00%

Profitability

Metric BGM CTOR Drug Manufacturers Specialty & Generic median
Gross margin 6.54% — 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 1.96% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (126.58%) (0.40%)
Return on assets 0.00% (45.20%) (3.32%)
Return on invested capital 0.00% (67.15%) 0.00%

Growth

Metric BGM CTOR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 10.01%
EPS growth (last fiscal year) 10.00% (9.68%) 49.06%
Revenue growth, 5-year CAGR (5.39%) — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM CTOR Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.50 0.05
Current ratio 1.25 0.73 2.31
Net debt to EBITDA 0.97 (0.40) 0.97

Dividend

Metric BGM CTOR Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric BGM CTOR Drug Manufacturers Specialty & Generic median
Market cap 114.71m 69.36m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack